Routine testing to reduce late HIV diagnosis in France

British Medical Journal

Volumn 334, Issue 7608, 2007, Pages 1354-1356

  Delpierre, Cyrille ^a,d   Cuzin, Lise ^b   Lert, France ^c  

^a Hôpital Purpan ^*

^b CHU PURPAN   (France)

^c INSERM   (France)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIAGNOSTIC TEST; FRANCE; HEALTH CARE; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL EXAMINATION; PRIORITY JOURNAL; SCREENING TEST; SEXUAL INTERCOURSE; TIME; COUNSELING; EARLY DIAGNOSIS; MASS SCREENING; ORGANIZATION AND MANAGEMENT; REVIEW;

COUNSELING; EARLY DIAGNOSIS; FRANCE; HEALTH POLICY; HIV INFECTIONS; HUMANS; MASS SCREENING;

EID: 34447105995     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39225.458218.94     Document Type: Article

References (21)

1. Institute de Veille Sanitaire. Surveillance du VIH/SIDA en France au 30 juin 2005. Paris: InVS, 2006.
2. Beltzer N, Lagarde M, Wu-Zhou X, Vongmany N, Gremy I. Les connaissances, attitudes, croyances et comportements face au VIH/SIDA en France. Paris: Sante Ordl, 2005.
3. Delpierre C, Dray-spira R, Cuzin L, Marchou B, Massip P, Lang T, et al. Correlates of late diagnosis in France. Implications for testing policy. Int J STD AIDS 2007;18:312-7.
4. Delpierre C, Cuzin L, Lauwers-Cances V, Marchou B, Lang T. High risk groups for late HIV diagnosis of HIV infection: a need for rethinking testing policy in the general population. AIDS Patient Care STDS 2006;20:238-47.
5. Sabin C, Smith C, Youle M, Lampe F, Bell D, Puradiredja D, et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS 2005;20:67-71.
6. Chadborn T, Baster K, Delpech V, Sabin C, Sinka K, Rice B, et al. No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993-2002). AIDS 2005;19:513-20.
7. Yeni R. Prise en charge therapeutique des personnes infectées par le VIH. Paris: Médecine-Sciencec, Flammarion, 2006.
8. Lewden C, Jougla E, Alioum A, Pavilion G, Lievre L, Morlat P, et al. Number of deaths among HIV-infected adults in France in 2000, three-source capture-recapture estimation. Epidemiol Infect 2006:1-8.
9. NIMH Multisite HIV prevention Trial. Reducing HIV sexual risk behavior. Science 1998;280:1889-94.
10. Kamb ML, Fishbein M, Douglas JM Jr, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. JAMA 1998;280:1161-7.
11. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000;342:921-9.
12. Cook J, Dasbach E, Coplan P, Markson L, Yin D, Meibohm A, et al. Modeling the long-term outcomes and costs of HIV antiretroviral therapy using HIV RNA levels: application to a clinical trial. AIDS Res Hum Retroviruses 1999;15:499-508.
13. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
14. De Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341-6.
15. Sanders GD, Bayoumi AM, Sundaram V, Bilir SP, Neukermans CP, Rydwak CE, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretrovirai therapy. N Engl J Med 2005;352:570-85.
16. Krentz H, Auld M, Gill M. The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection. HIV Med 2004;5:93-8.
17. Yazdanpanah Y, Goldie S, Losina E, Weinstein MC, Lebrun J, Paltiel AD, et al. Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy. Antivir Ther 2002;7:257-66.
18. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR, Losina E, Zhang H, et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med 2005;352:586-95.
19. Sidaction. Le sida en France. www.sidaction.org/informer/ sidafrance.
20. Centers for Disease Control and Prevention. Late versus early testing of HIV - 16 sites, United States, 2000-2003. MMWR: Morb Mortal Wkly Rep 2003;52:581-6.
21. Marks G, Crepaz N, Janssen R. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006;20:1447-50.